Public awareness of mibyou and preferences for disclosure and treatment among adults in Japan
Introduction: Mibyou (pre-symptomatic disease) is “a state between health and illness in which symptoms may occur without disease progression or abnormal test results may occur without symptoms.” This study examined public awareness of mibyou to inform ethical, legal, and social considerations related to its use in early disease prediction and prevention. Methods We conducted an anonymous online survey among 1,020 participants (510 men and 510 women) to assess perceptions of mibyou and preferences if identified as being in a mibyou state. Results Most participants were unaware of mibyou (52.1%); 17.9% had seen or heard of it, and 30% thought they might have encountered it before. Overall, 50.7% reported they would feel relieved if informed that they were in a mibyou state, whereas 47.6% expressed that they would feel anxious. Most preferred to be informed under all circumstances (46.4%) or if disclosure could help prevent disease or delay disease progression (48.6%). However, 4.5% preferred not to be informed under any circumstances. Furthermore, 49.5% preferred to start treatment immediately, whereas 49.1% preferred to monitor their condition before deciding. Conclusions Limited awareness of mibyou highlights the need for public awareness of the concept. Knowledge of a mibyou state cannot be reversed; therefore, disclosure should respect individuals’ right not to know and their right to make informed treatment decisions.
Authors
- Yoshihiko Iijima
- Ayako Kamisato (ORCID: https://orcid.org/0009-0003-7300-8812)
Institutions
- Fujita Health University (JP)
- National Center For Child Health and Development (JP)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11455116/v1
- Primary Topic
- Ethics and bioethics in healthcare
- Type
- preprint